Mason & Associates »

Sarepta Therapeutics shares owned by Mason & Associates

Quarter-by-quarter ownership of Sarepta Therapeutics (SRPT) shares owned by Mason & Associates from 13F filings

Historical chart of Mason & Associates investment in Sarepta Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sarepta Therapeutics held by Mason & Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sarepta Therapeutics by Mason & Associates

Quarter filed Position value Share count Share price at filing
2025-06-30 $191k 11k 17.10

More positions owned by Mason & Associates

J P Morgan Exchange Traded F Us Qualty Fctr (JQUA)
Columbia Etf Tr I Resh Enhnc Cor (RECS)
Dimensional Etf Trust Us Equity Market (DFUS)
American Centy Etf Tr Intl Eqt Etf (AVDE)
New York Life Investments Et Nyli Ftse Intern (HFXI)
Janus Detroit Str Tr Hendrson Aaa Cl (JAAA)
Vaneck Etf Trust Semiconductr Etf (SMH)
Vanguard Scottsdale Fds Shrt Trm Corp Bd (VCSH)
Ishares Tr Agency Bond Etf (AGZ)
Goldman Sachs Etf Tr S&p 500 Premium (GPIX)
American Centy Etf Tr Avantis Emgmkt (AVEM)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Spdr Series Trust Bloomberg Sht Te (SJNK)
Vanguard World Comm Srvc Etf (VOX)

View all positions for Mason & Associates

Top funds holding Sarepta Therapeutics

BlackRock
Vanguard Group
State Street Corporation
Susquehanna International
Erste Asset Management GmbH
Renaissance Technologies
Two Sigma Investments
D. E. Shaw & Co
UBS Group
Standard Life Aberdeen
Two Sigma Advisers
First Trust Advisors
Citadel Advisors
Bnp Paribas Arbitrage, Snc
Connor, Clark & Lunn Investment Management

View all funds holding Sarepta Therapeutics